Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 347

1.

Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.

Flowers CR, Seidenfeld J, Bow EJ, Karten C, Gleason C, Hawley DK, Kuderer NM, Langston AA, Marr KA, Rolston KV, Ramsey SD.

J Clin Oncol. 2013 Feb 20;31(6):794-810. doi: 10.1200/JCO.2012.45.8661. Epub 2013 Jan 14.

PMID:
23319691
2.

Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia.

van Dalen EC, Mank A, Leclercq E, Mulder RL, Davies M, Kersten MJ, van de Wetering MD.

Cochrane Database Syst Rev. 2016 Apr 24;4:CD006247. doi: 10.1002/14651858.CD006247.pub3. Review.

PMID:
27107610
3.

Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.

Mullen CA, Petropoulos D, Roberts WM, Rytting M, Zipf T, Chan KW, Culbert SJ, Danielson M, Jeha SS, Kuttesch JF, Rolston KV.

Cancer. 1999 Jul 1;86(1):126-34.

PMID:
10391572
4.
5.

[Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].

Jarque I, Sanz MA.

Enferm Infecc Microbiol Clin. 1999;17 Suppl 2:95-102. Review. Spanish.

PMID:
10605194
6.

Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.

Park JR, Coughlin J, Hawkins D, Friedman DL, Burns JL, Pendergrass T.

Med Pediatr Oncol. 2003 Feb;40(2):93-8.

PMID:
12461792
7.

[Prevention and treatment of febrile neutropenia].

Montemurro F, Gallicchio M, Aglietta M.

Tumori. 1997;83(2 Suppl):S15-9. Review. Italian.

PMID:
9235724
8.

Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Moen MD, Lyseng-Williamson KA, Scott LJ.

Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010. Review.

PMID:
19275278
9.
10.
11.

Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.

Klastersky J, Paesmans M, Georgala A, Muanza F, Plehiers B, Dubreucq L, Lalami Y, Aoun M, Barette M.

J Clin Oncol. 2006 Sep 1;24(25):4129-34.

PMID:
16943529
12.

Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin.

Chamilos G, Bamias A, Efstathiou E, Zorzou PM, Kastritis E, Kostis E, Papadimitriou C, Dimopoulos MA.

Cancer. 2005 Jun 15;103(12):2629-35.

13.

Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.

Tamura K.

Int J Antimicrob Agents. 2005 Dec;26 Suppl 2:S123-7; discussion S133-40. Epub 2005 Oct 24.

PMID:
16249072
14.

Clinical practice patterns of managing low-risk adult febrile neutropenia during cancer chemotherapy in the USA.

Freifeld A, Sankaranarayanan J, Ullrich F, Sun J.

Support Care Cancer. 2008 Feb;16(2):181-91. Epub 2007 Oct 18.

PMID:
17943327
15.

[Antimicrobial prophylaxis and therapy in neutropenia].

Link H.

Mycoses. 2003;46 Suppl 2:21-32. Review. German.

PMID:
15055140
17.

Safe and effective outpatient treatment of adults with chemotherapy-induced neutropenic fever.

Moores KG.

Am J Health Syst Pharm. 2007 Apr 1;64(7):717-22. Review.

PMID:
17384356
18.

Inpatient versus outpatient management of neutropenic fever in gynecologic oncology patients: is risk stratification useful?

Gunderson CC, Farrell R, Dinh BC, Thomas ED, Vesely SK, Lauer JK, Kao L, Chopra S, McMeekin DS, Moore KN.

Gynecol Oncol. 2013 Sep;130(3):411-5. doi: 10.1016/j.ygyno.2013.06.018. Epub 2013 Jun 20.

PMID:
23791827
19.

Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia.

Girmenia C, Russo E, Carmosino I, Breccia M, Dragoni F, Latagliata R, Mecarocci S, Morano SG, Stefanizzi C, Alimena G.

Ann Hematol. 2007 Apr;86(4):263-70. Epub 2007 Jan 16.

PMID:
17225113
20.

Outpatient management of febrile neutropenia in children with cancer.

Holdsworth M, Hanrahan J, Albanese B, Frost J.

Paediatr Drugs. 2003;5(7):443-55. Review.

PMID:
12837117

Supplemental Content

Support Center